RecruitingNCT02889016

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS


Sponsor

Stanford University

Enrollment

500 participants

Start Date

Mar 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.


Eligibility

Min Age: 4 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating PANS (Paediatric Acute-onset Neuropsychiatric Syndrome) — a condition in children where OCD, food restriction, or other neuropsychiatric symptoms appear very suddenly and dramatically. Researchers at Stanford are looking for biological markers (neurological, immunological, and rheumatological) that might explain why these episodes happen and how to treat them better. You may be eligible if: - You are a child aged 1–18 at onset of PANS symptoms OR a healthy control aged 4–18 - Your child experienced a sudden onset of OCD or food restriction, plus at least two other symptoms (e.g. frequent urination, worsening handwriting, mood changes, anxiety) - You live within 90 miles of Stanford University and have had a new PANS onset - Healthy controls should have no psychiatric diagnosis You may NOT be eligible if: - You have another neuropsychiatric illness that makes a clear diagnosis of PANS uncertain Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Stanford University

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02889016


Related Trials